2026/01/01 by Yongbo She, Kaizhen Jia, Adrianne Cardillo +5 · 1 voice
Chemistry · Nursing · #Coconut Research and Applications #Fatty Acid Research and Health #Nuts composition and effects
paper · pdf · doi:10.1039/d5fo04672f
openalex publication_date 2026/01/01 · openalex created_date 2026/02/25 · openalex updated_date 2026/07/12
were included. Participants consumed both hemp products and controlled products over the course of 4 weeks each. As expected, ALA (18:3 n-3), GLA (18:3 n-6) and dihomo-γ-linolenic acid (DGLA, 20:3 n-6) were elevated after the hemp treatment than controls. Similarly, ALA, DGLA as well as eicosapentaenoic acid (EPA) levels were elevated after the hemp treatment than controls. No differences in serum lipid levels, glucose and insulin concentrations, blood pressure, or body composition were observed between treatments. Overall, consumption of hemp products modulated plasma and RBC fatty acids levels in a way which reflected the fatty acids these products are enriched in, without showing differences in major cardiometabolic risk factors. The present study demonstrated the human fatty acids profile response to consuming hemp products, novel functional foods rich in polyunsaturated fatty acids. The clinical trial registry number is NCT02400203 (https://clinicaltrials.gov).